← All indications
Cholestasis, Intrahepatic
Impairment of bile flow due to injury to the HEPATOCYTES; BILE CANALICULI; or the intrahepatic bile ducts (BILE DUCTS, INTRAHEPATIC).
Subtype terms (2)
More specific conditions that are subtypes of Cholestasis, Intrahepatic in the MeSH hierarchy.
- Alagille Syndrome
6 drugs approved
- Liver Cirrhosis, Biliary
74 drugs (40 approved, 34 experimental)
Drugs by status
Approved for this indication (1)
Phase 3 trials (9)
Phase 2 trials (1)
Organizations
Organization Involved with Phase 3 Indications (11)
Organization Involved with Phase 2 Indications (1)
Organization Involved with Other Experimental Indications (2)